(Press-News.org)
(Helsinki, Finland, Saturday, 21 June 2025) New research, presented today at the European Academy of Neurology (EAN) Congress 2025, has uncovered a powerful link between nighttime heart rhythm and future health conditions, even in people with no obvious sleep problems.1
The study, which was conducted at the Department of Neurology, Inselspital, the University Hospital of Bern, analysed 4,170 individuals over an observation period of 13,217 person-years, found that heart rate variability (HRV) during sleep can serve as a powerful early warning sign of future health conditions, including stroke, depression, and cognitive dysfunction.
HRV reflects the fluctuation of time intervals between heartbeats.2 HRV adjusts constantly in response to physical and emotional demands of the body. During the day, HRV is physiologically high corresponding to high levels of activity. At night, and especially during deep sleep, HRV typically reduces, reflecting a shift into a rest and repair mode, where the body focuses on recovery and recharging for the next day.
The research found that certain HRV patterns were linked to future health conditions. Participants who later developed stroke often showed unusually high and erratic HRV. In contrast, low HRV was common in those who further developed depression. High HRV with altered frequency patterns were also observed in individuals who later developed metabolic diseases. Similarly, cardiovascular and endocrine diseases were also associated with high HRV.
“HRV matters for brain and overall health because it reflects how well the body regulates itself – primarily through the activity of the autonomic nervous system”, explained the lead author of the study, Irina Filchenko, MD, PhD. “This system controls vital unconscious processes such as breathing, digestion and muscle tone, helping the body maintain balance and adapt to internal and external demands.”
“While many people are familiar with tracking sleep stages or total sleep time, nocturnal HRV provides a unique window into how the body functions during sleep. This is especially important because sleep is a critical time for many physiological processes underlying long-term health, such as cellular repair, memory consolidation, and the clearance of metabolic waste from the brain.”
Importantly, researchers believe that HRV could act as an early physiological marker, demonstrating subtle changes in body functioning before traditional symptoms or diagnoses appear. This could open the door to prevention and early intervention for diseases like Alzheimer's or stroke, where timely action can improve patient outcomes.
Dr Filchenko noted, “Some participants had ‘normal’ sleep according to traditional criteria, with little sleep fragmentation and the expected balance of sleep stages. However, HRV told a different story, picking up risks that the common sleep metrics missed. This suggests we need to rethink how we define and measure optimal sleep.”
The findings of the study also raise the possibility of using wearable technology to monitor HRV patterns over time. While current consumer devices vary in accuracy and interpretability, experts believe future improvements could allow people to track changes in HRV as part of regular health monitoring.
The research adds to growing evidence that sleep is a critical pillar of long-term health, and that subtle patterns could offer a window of opportunity to prevent serious disease. “The broader message is that sleep is not just a passive state of rest — it is an active, dynamic process that plays a vital role in maintaining long-term health, especially brain health. Our findings reinforce the idea that primary prevention matters, and that health problems start long before the clinical symptoms appear”, concluded Dr Filchenko.
ENDS
Notes to Editors:
Press Enquiries:
A reference to the EAN Congress 2025 must be included when communicating the information within this press release.
For further information or to speak to an expert, please contact the press team at press@ean.org.
About the Expert:
Irina Filchenko, MD, PhD, is a physician-scientist with a background in neurology and sleep medicine. She obtained her medical degree from Pavlov University (St. Petersburg) and completed a PhD in Neuroscience at the University of Bern under the supervision of Prof. Claudio L. A. Bassetti and PD Markus H. Schmidt, MD, PhD. Dr Filchenko is completing her neurology residency at the Inselspital, the University Hospital of Bern. Her research focuses on the relationship between sleep, brain health, neurological disorders and their prevention, course, and recovery.
About the EAN:
EAN is a non-profit, independent organisation representing more than 45,000 members, as well as 48 European national societies. As a medical society we promote excellence in the practice of general neurology throughout Europe, leading to improved patient care.
We also aim to keep Europe at the forefront of neurological research and maintain its position as one of the world’s leading scientific hotspots in neurology.
Learn more: ean.org
References:
Filchenko, I. Sleep and longevity: insights from sleep macroarchitecture and nocturnal heart rate variability. Presented at the European Academy of Neurology (EAN) Congress 2025; 21 June 2025; Helsinki, Finland.
Shaffer, F., & Ginsberg, J. P. (2017). An Overview of Heart Rate Variability Metrics and Norms. Frontiers in public health, 5, 258. https://doi.org/10.3389/fpubh.2017.00258 END
Scientists and engineers study the atomic interactions that happen on the surface of materials to develop more energy efficient batteries, capacitors, and other devices. But accurately simulating these fundamental interactions requires immense computing power to fully capture the geometrical and chemical intricacies involved, and current methods are just scratching the surface.
“Currently it’s prohibitive and there’s no supercomputer in the world that can do an analysis like that,” says Siddharth Deshpande, an assistant professor in the University of Rochester’s Department of Chemical Engineering. “We need clever ways to manage ...
June 18, 2025 - The highly anticipated 2024 Journal Citation Reports (JCR) were officially released today, marking a significant achievement for Current Molecular Pharmacology (CMP). The journal's 2024 Impact Factor has increased to 2.9, with a five-year Impact Factor of 3.1, successfully advancing to the Q2 zone in the PHARMACOLOGY & PHARMACY category. This accomplishment signifies a notable enhancement in CMP's academic influence and recognition.
CMP is dedicated to publishing the latest advancements ...
For many patients, radioactive iodine treatment after thyroid cancer surgery means side effects like nausea and time in hospital isolated from loved ones. But new clinical trial results from researchers at UCL mean hundreds of thousands of patients worldwide could now safely be spared this treatment.
Globally, around 820,000 people are diagnosed with thyroid cancer each year. Compared to most cancers, it affects a high proportion of younger people who are more likely to be parents to young children. It is also three times more common in women than men.
The Iodine or Not (IoN) clinical ...
NEW YORK, NY (June 20, 2025)—A new laboratory method developed by researchers at Columbia University Vagelos College of Physicians and Surgeons may now help physicians more quickly diagnose patients with suspected genetic disorders of the immune system, many who have been trapped in diagnostic limbo for years.
The researchers, who published their findings June 20 in Cell, applied the method to one rare inborn error of immunity called activated-PI3Kδ syndrome (APDS) and found dozens of additional genetic variations that could cause the syndrome.
“Our findings give physicians a resource that can help them rapidly diagnose and treat ...
(MEMPHIS, Tenn. – June 20, 2025) The relationship between genetic variants and the risk of late-onset cardiomyopathy remains poorly understood in survivors of childhood cancer despite being otherwise well established. Scientists from St. Jude Children’s Research Hospital have helped address this gap, assessing whether variant trends seen in the general population also apply to late-onset cardiomyopathy in five-year survivors of childhood cancer. The work revealed that, as in the general population, common variants in TTNand BAG3 are associated with reduced late-onset cardiomyopathy ...
The Simons Foundation Autism Research Initiative (SFARI) has released phenotypic and genetic data from the Autism Inpatient Collection (AIC), a cohort of more than 1,500 youth participants ages 4 to 20 years old who were hospitalized in one of six child psychiatry units in the United States. The AIC, supported by SFARI and the Nancy Lurie Marks Family Foundation, aimed to engage these individuals, many of whom meet recently proposed criteria for ‘profound autism’ (autism characterized by intellectual disability or minimal language that requires high ...
Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute today report the identification of a novel combination therapy approach to treat pediatric acute myeloid leukemia (AML). Standard treatment is often ineffective against AML, a cancer that commonly relapses with poor prognosis, particularly when the disease is fueled by fusion proteins involving NUP98. The researchers documented how these fusions drive disease, discovering a protein complex required to express cancer-promoting genes. When they targeted the complex alone or in combination with another anticancer drug, survival significantly ...
PROVIDENCE, R.I. [Brown University] — Climbing the social ladder isn’t simply a matter of popularity. Rather, people in positions of influence are particularly adept at forming “maps” of their social connections, which they navigate to become prominent in their social network, new research shows.
It’s like having a “social superpower,” according to study author Oriel FeldmanHall, an associate professor of cognitive and psychological sciences at Brown University who is affiliated with the University’s Carney Institute for Brain Science.
“People vary ...
A new study reveals that when we experience short-term (acute) pain, the brain has a built-in way to dial down pain signals — like pressing the brakes — to keep them from going into overdrive. But in long-term (chronic) pain, this braking system fails, and the pain signals just keep firing. This discovery helps explain why some pain goes away while other pain lingers, and it opens the door to new treatments that could stop pain from becoming chronic in the first place.
Why does some pain go away ...
The Earth is rapidly warming — but did you know? Similar climate upheavals over 300 million years ago once triggered massive fluctuations in marine life.
Recently, a research team led by Prof. Shuzhong Shen of Nanjing University published a major finding in Science Advances, revealing for the first time — through high-precision big data — that during the Late Paleozoic (approximately 340 to 250 million years ago), global cooling promoted rapid evolution and diversification of marine life, while abrupt warming, especially that induced by volcanic eruptions, led to mass extinctions.
The focus of the study is an ancient group of single-celled marine organisms ...
